Cadila gets USFDA approval for blood pressure treatment drug
Zydus Cadila has received final approval to market Candesartan Cilexetil and Hydrochlorothiazide tablets formulations, from the US health regulator. It is used for treating high blood...
Tag : USFDA
Glenmark Pharma receives 7 observations for Baddi unit, from USFDA
Glenmark Pharma’s, Baddi manufacturing unit has received 7 observations, from the US health regulator after an audit. Its Baddi unit contributes approx 10% of the revenue...
Cadila receives USFDA approval for acne drug
Zydus Cadila has received final approval to market minocycline hydrochloride extended release tablets, which is used for treating acne, from the US health regulator. The drug...
Cadila receives USFDA approval, to sell erectile dysfunction drug
Zydus Cadila has received approval to market Tadalafil tablets in the US market, from the US health regulator. It is used for treatment of erectile dysfunction and...
Glenmark receives consent for contraceptive drug from USFDA
Glenmark Pharmaceuticals has received final approval from the US health regulator, for a generic version of Loestrin tablets, which is used to prevent pregnancy. In...
Strides Shasun receives USFDA approval for altitude sickness tablets
Strides Shasun’s wholly-owned subsidiary has received green signal from the US health regulator, for Acetazolamide tablets. It is used to prevent and reduce symptoms of altitude sickness. In...
Dr Reddy’s receives EIR from USFDA, for Vizag plant
Dr.Reddy’s Laboratories has received an establishment inspection report (EIR), for its formulation manufacturing facility at Duvvada in Visakhapatnam, from the US health regulator. The company has...
Cipla receives USFDA approval for generic Dacogen
Cipla has received final approval for generic version of Dacogen, from the US health regulator, which is suggested for treatment of myelodysplastic syndromes. Cipla in...
Biocon facility receives inspection closure report from USFDA
Biocon has received the Establishment Inspection Report, from the USFDA with voluntary action indicated status, on closure of inspection of its aseptic drug product facility....
Cipla receives final approval for anti-asthma product from USFDA
US health regulator has given final approval to Cipla, for a suspension product used for treating asthma. Cipla in a BSE filing today stated, “it...